VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 102 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $2,895,000 | +275.5% | 110,806 | +129.2% | 0.79% | +663.1% |
| Q4 2016 | $771,000 | -34.6% | 48,354 | -31.8% | 0.10% | -34.8% |
| Q3 2016 | $1,179,000 | +10.5% | 70,858 | +7.5% | 0.16% | -21.8% |
| Q2 2014 | $1,067,000 | -69.7% | 65,936 | -79.5% | 0.20% | -71.3% |
| Q3 2013 | $3,527,000 | +64.7% | 321,548 | +21.3% | 0.70% | +51.2% |
| Q2 2013 | $2,141,000 | – | 265,012 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |